BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37079029)

  • 21. Limited impact of discretization/interpolation parameters on the predictive power of CT radiomic features in a surgical cohort of pancreatic cancer patients.
    Loi S; Mori M; Palumbo D; Crippa S; Palazzo G; Spezi E; Del Vecchio A; Falconi M; De Cobelli F; Fiorino C
    Radiol Med; 2023 Jul; 128(7):799-807. PubMed ID: 37289267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
    Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
    Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Rigiroli F; Hoye J; Lerebours R; Lyu P; Lafata KJ; Zhang AR; Erkanli A; Mettu NB; Morgan DE; Samei E; Marin D
    Eur Radiol; 2023 Aug; 33(8):5779-5791. PubMed ID: 36894753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 25. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
    Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
    J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of interobserver and interdisciplinary segmentation variabilities on CT-based radiomics for pancreatic cancer.
    Wong J; Baine M; Wisnoskie S; Bennion N; Zheng D; Yu L; Dalal V; Hollingsworth MA; Lin C; Zheng D
    Sci Rep; 2021 Aug; 11(1):16328. PubMed ID: 34381070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma.
    Salinas-Miranda E; Healy GM; Grünwald B; Jain R; Deniffel D; O'Kane GM; Grant R; Wilson J; Knox J; Gallinger S; Fischer S; Khokha R; Haider MA
    Eur Radiol; 2022 Oct; 32(10):6712-6722. PubMed ID: 36006427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A CT Radiomics-Based Risk Score for Preoperative Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma.
    Zhou Y; Wang J; Zhang SL; Wang H; Yan Y; Qi X; Chen S; Chen FM
    Ann Surg Oncol; 2023 Feb; 30(2):1206-1216. PubMed ID: 36264518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics in precision medicine for gastric cancer: opportunities and challenges.
    Chen Q; Zhang L; Liu S; You J; Chen L; Jin Z; Zhang S; Zhang B
    Eur Radiol; 2022 Sep; 32(9):5852-5868. PubMed ID: 35316364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics in the evaluation of ovarian masses - a systematic review.
    Adusumilli P; Ravikumar N; Hall G; Swift S; Orsi N; Scarsbrook A
    Insights Imaging; 2023 Oct; 14(1):165. PubMed ID: 37782375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
    Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
    Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
    [No Abstract]   [Full Text] [Related]  

  • 32. Repeatability and Reproducibility of Radiomic Features: A Systematic Review.
    Traverso A; Wee L; Dekker A; Gillies R
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1143-1158. PubMed ID: 30170872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
    Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
    Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of commercially available vs. in-house radiomics software in classification of CT images from patients with pancreatic ductal adenocarcinoma vs. healthy controls.
    Chu LC; Solmaz B; Park S; Kawamoto S; Yuille AL; Hruban RH; Fishman EK
    Abdom Radiol (NY); 2020 Aug; 45(8):2469-2475. PubMed ID: 32372206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of Pancreatic Ductal Adenocarcinoma.
    He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
    Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-radiotherapy stage III/IV non-small cell lung cancer radiomics research: a systematic review and comparison of CLEAR and RQS frameworks.
    Tran K; Ginzburg D; Hong W; Attenberger U; Ko HS
    Eur Radiol; 2024 Apr; ():. PubMed ID: 38625613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma.
    Attiyeh MA; Chakraborty J; McIntyre CA; Kappagantula R; Chou Y; Askan G; Seier K; Gonen M; Basturk O; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Allen PJ; Iacobuzio-Donahue CA; Simpson AL; Do RK
    Abdom Radiol (NY); 2019 Sep; 44(9):3148-3157. PubMed ID: 31243486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas.
    Permuth JB; Vyas S; Li J; Chen DT; Jeong D; Choi JW
    Front Oncol; 2021; 11():712950. PubMed ID: 34367997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
    Meng Y; Yu J; Zhu M; Zhou J; Li N; Liu F; Zhang H; Fang X; Li J; Feng X; Wang L; Jiang H; Lu J; Shao C; Bian Y
    Abdom Radiol (NY); 2022 Aug; 47(8):2822-2834. PubMed ID: 35451626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.